Hydrogel macroporosity and the prolongation of transgene expression and the enhancement of angiogenesis

Biomaterials

Volumn 33, Issue 30, 2012, Pages 7412-7421

  Shepard, Jaclyn A ^a   Virani, Farrukh R ^a   Goodman, Ashley G ^a   Gossett, Timothy D ^b   Shin, Seungjin ^a   Shea, Lonnie D ^a,b,c  

^a Northwestern University   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Cell infiltration; Gelatin microspheres; Gene delivery; Macroporous hydrogel; Vascularization; VEGF

Indexed keywords

CELL INFILTRATION; GELATIN MICROSPHERES; GENE DELIVERY; MACROPOROUS HYDROGELS; VASCULARIZATION; VEGF;

BACTERIOPHAGES; CELLS; CYTOLOGY; GELATION; GENE TRANSFER; MICROSPHERES; TISSUE;

HYDROGELS;

GELATIN; LENTIVIRUS VECTOR; MACROGOL; MICROSPHERE; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CELL GROWTH; CELL INFILTRATION; CONTROLLED STUDY; DISSOLUTION; GELATION; GENE EXPRESSION; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; HYDROGEL; IN VITRO STUDY; IN VIVO STUDY; INCUBATION TEMPERATURE; MICROENCAPSULATION; NONHUMAN; POROSITY; PRIORITY JOURNAL; TISSUE REGENERATION; TRANSGENE; VASCULARIZATION; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; COLLAGEN; GELATIN; GENE EXPRESSION; HEK293 CELLS; HUMANS; HYDROGEL; LENTIVIRUS; MALE; MICE; MICROSPHERES; NEOVASCULARIZATION, PHYSIOLOGIC; PARTICLE SIZE; POLYETHYLENE GLYCOLS; POROSITY; SUS SCROFA; TRANSDUCTION, GENETIC; TRANSGENES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

LENTIVIRUS;

EID: 84864977276     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2012.06.081     Document Type: Article

References (45)

1. Ford M., Bertram J., Hynes S., Michaud M., Li Q., Young M. A macroporous hydrogel for the coculture of neural progenitor and endothelial cells to form functional vascular networks in vivo. Proc Natl Acad Sci USA 2006, 103:2512-2517.
2. Park J., Lim E., Back S., Na H., Park Y., Sun K. Nerve regeneration following spinal cord injury using matrix metalloproteinase-sensitive, hyaluronic acid-based biomimetic hydrogel scaffolds containing brain-derived neurotrophic factor. J Biomed Mater Res A 2010, 93A:1091-1099.
3. Lutolf M., Weber F., Schmokel H., Schense J., Kohler T., Müller R. Repair of bone defects using synthetic mimetics of collagenous extracellular matrices. Nat Biotechnol 2003, 21:513-518.
4. Patterson J., Slew R., Herring S., Lin A., Guldberg R., Stayton P. Hyaluronic acid hydrogels with controlled degradation properties for oriented bone regeneration. Biomaterials 2010, 31:6772-6781.
5. Hwang Y., Sangaj N., Varghese S. Interconnected macroporous poly(ethylene glycol) cryogels as a cell scaffold for cartilage tissue engineering. Tissue Eng Part A 2010, 16:3033-3041.
6. Park K., Lee S., Joung Y., Na J., Lee M., Park K. Thermosensitive chitosan-pluronic hydrogel as an injectable cell delivery carrier for cartilage regeneration. Acta Biomater 2009, 5:1956-1965.
7. Chui Y.-C., Cheng M.-H., Engel H., Kao S.-W., Larson J. The role of pore size on vascularization and tissue remodeling in PEG hydrogels. Biomaterials 2011, 32:6045-6051.
8. Zisch A., Lutolf M., Ehrbar M., Raeber G., Rizzi S., Davies N. Cell-demanded release of VEGF from synthetic, biointeractive cell-ingrowth matrices for vascularized tissue growth. FASEB J 2003, 2:2260-2262.
9. Peppas N., Bures P., Leobandung W., Ichikawa H. Hydrogels in pharmaceutical formulations. Eur J Pharm Biopharm 2000, 50:27-46.
10. Nguyen K., West J. Photopolymerizable hydrogels for tissue engineering applications. Biomaterials 2002, 23:4307-4314.
11. Zhu J. Bioactive modification of poly(ethylene glycol) hydrogels for tissue engineering. Biomaterials 2010, 31:4639-4656.
12. Anderson S., Chen T., Iruela-Arispe M., Segura T. The phosphorylation of vascular endothelial growth factor receptor-2 (VEGFR-2) by engineered surfaces with electrostatically or covalently immobilized VEGF. Biomaterials 2009, 30:4618-4628.
13. Shin S., Shea L. Lentivirus immobilization to nanoparticles for enhanced and localized delivery from hydrogels. Mol Ther 2010, 18:700-706.
14. Kidd M., Shin S., Shea L. Fibrin hydrogels for lentiviral gene delivery in vitro and in vivo. J Control Release 2012, 157:80-85.
15. Annex B., Simons M. Growth factor-induced therapeutic angiogenesis in the heart: protein therapy. Cardiovasc Res 2005, 65:649-655.
16. Cleland J., Duenas E., Park A., Daughtery A., Kahn J., Kowalski J. Development of poly(d, l-lactide-coglycolide) microsphere formulations containing recombinant human vascular endothelial growth factor to promote local angiogenesis. J Control Release 2001, 72:13-24.
17. Houchin-Ray T., Zelivyanskaya M., Huang A., Shea L. Non-viral gene delivery transfection profiles influence neuronal architecture in an in vitro co-culture model. Biotechnol Bioeng 2009, 103:1023-1033.
18. Quick D., Anseth K. DNA delivery from photocrosslinked PEG hydrogels: encapsulation efficiency, release profiles, and DNA quality. J Control Release 2004, 96:341-351.
19. Fang J., Zhu Y.-Y., Smiley E., Bonadio J., Rouleau J., Goldstein S. Stimulation of new bone formation by direct transfer of osteogenic plasmid genes. Proc Natl Acad Sci USA 1996, 93:5753-5758.
20. Raeber G., Lutolf M., Hubbell J. Molecularly engineered PEG hydrogels: a novel model system for proteolytically mediated cell migration. Biophys J 2005, 89:1374-1388.
21. Bengali Z., Pannier A., Segura T., Anderson B., Jang J.-H., Mustoe T. Gene delivery through cell culture substrate adsorbed DNA complexes. Biotechnol Bioeng 2005, 90:290-302.
22. Croyle M., Callahan S., Auricchio A., Schumer G., Linse K., Wilson J. PEGylation of a vesicular stomatitis virus G pseudotyped lentivirus vector prevents inactivation in serum. J Virol 2004, 78:912-921.
23. Shepard J., Huang A., Shikanov A., Shea L. Balancing cell migration with matrix degradation enhances gene delivery to cells cultured three-dimensionally within hydrogels. J Control Release 2010, 146:128-135.
24. Shepard J., Wesson P., Wang C., Stevans A., Holland S., Shikanov A. Gene therapy vectors with enhanced transfection based on hydrogels modified with affinity peptides. Biomaterials 2011, 32:5092-5099.
25. Shepard J., Stevans A., Holland S., Wang C., Shikanov A., Shea L. Hydrogel design for supporting neurite outgrowth and promoting gene delivery to maximize neurite extension. Biotechnol Bioeng 2012, 109:830-839.
26. Tabata Y., Hijikata S., Muniruzzaman M., Ikada Y. Neovascularization effect of biodegradable gelatin microspheres incorporating basic fibroblast growth factor. J Biomater Sci Polym Ed 1999, 10:79-94.
27. Lutolf M., Hubbell J. Synthesis and physiochemical characterization of end-linked poly(ethylene glycol)-co-peptide hydrogels formed by Michael-type addition. Biomacromolecules 2003, 4:713-722.
28. Aviles M., Shea L. Hydrogels to modulate lentivirus delivery in vivo from microporous tissue engineering scaffolds. Drug Deliv Transl Res 2011, 1:91-101.
29. Nielsen L., Moe D., Kirkeby S., Garbarsch C. Sirius red and acid fuchsin staining mechanisms. Biotech Histochem 1998, 73:71-77.
30. De Laporte L., Yan A., Shea L. Local gene delivery from ECM-coated poly(lactide-co-glycolide) multiple channel bridges after spinal cord injury. Biomaterials 2009, 30:2361-2368.
31. Yang S., Leong K.-F., Du Z., Chua C.-K. The design of scaffolds for use in tissue engineering. Part I. Traditional factors. Tissue Eng 2001, 7:679-689.
32. Mooney D., Baldwin D., Suh N., Vacanti J., Langer R. Novel approach to fabricate porous sponges of poly(d, l-lactic-co-glycolic acid) without the use of organic solvents. Biomaterials 1996, 17:1417-1422.
33. Yang C., Jenkins L., Burg K. Adapted cryosectioning method for hydrogels used in regenerative medicine. J Histotechnol 2007, 30:185-191.
34. Chirila T., Constable I., Crawford G., Vijayasekaran S., Thompson D., Chen Y.-C. Poly(2-hydroxyethyl methacrylate) sponges as implant materials: in vivo and in vitro evaluation of cellular invasion. Biomaterials 1993, 14:26-38.
35. Haralabopoulos G., Grant D., Kleinman H., Lelkes P., Papaioannou S., Maragoudakis M. Inhibitors of basement membrane collagen synthesis prevent endothelial cell alignment in matrigel in vitro and angiogenesis in vivo. Lab Invest 1994, 71.
36. Senger D., Claffey K., Benes J., Perruzzi C., Sergiou A., Detmar M. Angiogenesis promoted by vascular endothelial growth factor: regulation through α1β1 and α2β1 integrins. Proc Natl Acad Sci USA 1997, 94:13612-13617.
37. Lutolf M., Lauer-Fields J., Schmoekel H., Metters A., Weber F., Fields G. Synthetic matrix metalloproteinase-sensitive hydrogels for the conduction of tissue regeneration: engineering cell-invasion characteristics. Proc Natl Acad Sci USA 2003, 100:5413-5418.
38. Whang K., Healy K., Elenz D., Nam E., Tsai D., Thomas C. Engineering bone regeneration with bioabsorbable scaffolds with novel microarchitecture. Tissue Eng 1999, 5:35-51.
39. Aviles M., Lin C.-H., Zelivyanskaya M., Graham J., Boehler R., Messersmith P. The contribution of plasmid design and release to in vivo gene expression following delivery from cationic polymer modified scaffolds. Biomaterials 2010, 31:1140-1147.
40. Shin S., Tuinstra H., Salvay D., Shea L. Phosphatidylserine immobilization of lentivirus for localized gene transfer. Biomaterials 2010, 31:4353-4359.
41. Kim B., Mooney D. Development of biocompatible synthetic extracellular matrices for tissue engineering. Trends Biotechnol 1998, 16:224-230.
42. Hollister S. Porous scaffold design for tissue engineering. Nat Mater 2005, 4:518-524.
43. Carmeliet P., Jain R. Angiogenesis in cancer and other diseases. Nature 2000, 407:249-257.
44. Ferrara N., Gerber H.-P., LeCouter J. The biology of VEGF and its receptors. Nat Med 2003, 9:669-676.
45. Lazarous D., Shou M., Scheinowitz M., Hodge E., Thirumurti V., Kitsiou A. Comparative effects of basic fibroblast growth factor and vascular endothelial growth factor on coronary collateral development and the arterial response to injury. Circulation 1996, 94:1074-1082.